Forte Research Systems and Virtify Partner for Simplified Compliance with Disclosure Regulations
MADISON, Wis. and CAMBRIDGE, Mass. -- Forte Research Systems, Inc., a leading developer of specialized clinical trial management systems (CTMS), and Virtify, Inc., a leading provider of structured content management software solutions for life sciences, announced today a partnership that will simplify compliance with disclosure requirements of the Food and Drug Administration Amendments Act (FDAAA). The agreement addresses the increasingly stringent regulations imposed on clinical research institutions.
The integration will take place between Forte's OnCore® system, the nation's most widely adopted enterprise-class clinical research management system among academic medical centers and cancer centers, and the Virtify CTRR (Clinical Trial Registration & Results) software, which streamlines and automates the mandatory disclosure postings to the ClinicalTrials.gov online registry and results database.
"Collaborating with Virtify allows us to provide a seamless and sophisticated experience for OnCore users as they comply with these regulations," said Srini Kalluri, Founder, CEO, and Chief Customer Officer at Forte. "OnCore is a proven system that supports streamlined management of robust portfolios of clinical trials. Coupled with the many benefits of the Virtify CTRR, OnCore becomes the most comprehensive solution available for compliance with clinical trial disclosure requirements."
Among the benefits offered by Virtify CTRR is an easy-to-use centralized compliance monitoring system for clinical trials. It offers the status of all trial disclosures and helps users proactively identify their risks related to trial disclosure and non-compliances.
When integrated with the OnCore system, the Virtify solution will provide an end-to-end disclosure solution. "It will extend CTRR's robust disclosure process management features to the OnCore system, which in turn will be able to share data directly with Virtify CTRR," said Satish Tadikonda, CEO of Virtify. "The ability of the systems to communicate means that duplicate data entry will be eliminated."
The new agreement is the most recent among several collaborations in which Forte has joined with industry leaders to provide comprehensive solutions and eliminate data silos. "With Virtify's extensive experience and expertise in the clinical trial disclosure arena, it makes perfect sense to partner with them rather than reinventing the wheel," Kalluri said. "This will continue to be our strategy in order to bring greater efficiencies to the industry."
Learn More about Disclosure Regulations
Forte will host a free educational webinar for clinical research institutions interested in learning more about disclosure regulations for clinical trials. Titled "Disclosure Requirements for ClinicalTrials.gov: What Institutions Need to Know," it will be presented by top industry expert Barbara Godlew, President and Principal Analyst at The FAIRE Company, LLC. During the webinar, Godlew will share her expertise on pivotal topics, including current clinical trial disclosure requirements and regulations, newly introduced ICMJE-endorsed legislation that could expand current requirements, and much more. Registration is required and open to the public. For more information, visit
About Forte Research Systems, Inc.
Forte Research Systems, Inc. develops specialized clinical trial management software systems (CTMS). Mid-sized to large academic medical centers, research hospitals, and cancer centers rely on Forte's OnCore system, which boasts a broad technological footprint comprised of CTMS, EDC, biospecimen management, and patient-oriented research management functionality for organizations with robust portfolios of clinical trials. Investigator sites, research groups, and investigator site networks value the flexibility and small footprint of the Allegro® family of cloud-based clinical trial management systems.
About Virtify, Inc.
Virtify is the market leader in structured content management software solutions for life sciences. Organizations rely on Virtify solutions to reduce time-to-market, risk, and costs by managing and automating the complex regulatory compliance and content exchange requirements throughout the product life cycle.
SOURCE Forte Research Systems, Inc.; Virtify, Inc.